sensei(SNSE) - 2023 Q4 - Annual Results

Exhibit 99.1 Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights - Strong balance sheet with cash runway into fourth quarter of 2025 - BOSTON, MA – February 28, 2024 – Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients, today reported financial results for the full year 2023, and provided corporate updates. "2023 saw the entry of our diffe ...